维普期刊资源整合服务平台（V6.5）

30篇 您的检索式：作者名="Keohan ML"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Phase II study of sor- afenib in patients with metastatic or recurrent sarcomas显示文摘	Maki RG D'Adamo DR Keohan ML	2009	J Clin Onco12009，27，19：	1
2	Peritoneal mesothelioma显示文摘	Taub RN Keohan ML Chabot JC	2000	Curr Treat Options Oncol2000，1，4：	1
3	Peritoneal mesothelioma 显示文摘	Taub RN Keohan ML Chabot JC	2000	Curr Treat Options Oncol2000，1，4：	1
4	Phase II study of sorafenib in patients with metastatic or recurrent sarcomas显示文摘	Maki RG D'Adamo DR Keohan ML		0，，：	1
5	The frequent expression of cancer/testis antigens provides opportunities for immunothera- peutic targeting of sarcoma 显示文摘	Ayyoub M Taub RN Keohan ML	2004	Cancer Immun2004，4，：	1
6	Peritoneal mesothelioma 显示文摘	Taub RN Keohan ML Chabot JC	2000	Crr Treat Options Oncol2000，1，4：	1
7	Phase II study of sorafenib in patients with metastatic or recurrent sarcomas显示文摘	Maki RG D' Adamo DR Keohan ML	2009	J Clin Oncol2009，27，19：	1
8	Peritoneal mesothelioma显示文摘	Taub RN Keohan ML Chabot JC	2000	Currt Treat Options Oncol2000，1，4：	1
9	The frequent expression of cancer/testis antigens provides opportunities for immunotherapeutic targeting of sarcoma显示文摘	Ayyoub M Taub RN Keohan ML	2004	Cancer Immun2004，4，：	1
10	A phase II tri- al of temozolomide in patients with unresectable or meta- static soft tissue sarcoma显示文摘	Talbot SM Keohan ML Hesdorffer M	2003	Cancer2003，98，9：	1
11	Phase Ⅱ study of temozolomide and thalidomide in patients with unresectable or metastatic leiomyosarcoma显示文摘	Boyar M Keohan ML Hesdorffer M	2005	J Clin Oncol2005，23，16：	1
12	Phase H study of sor- afenib in patients with metastatic or recurrent sarcomas显示文摘	Maki RG D~damo DR Keohan ML	2009	J Clin Oncol2009，27，19：	1
13	Chemotherapy for advanced sarcoma: therapeutic decisions and modalities 显示文摘	Keohan ML Tanb RN	1997	Semin Oncol1997，24，5：	1
14	Clinical out- comes of systemic therapy for patients with deep fibromatosis ( des- mold tumor)显示文摘	de Camargo VP Keohan ML D'Adamo DR	2010	Cancer2010，116，9：	1
15	Phase Ⅱ study of sorafenib in patients with metastatic or recurrent sarcomas 显示文摘	Maki RG D'Adamo DR Keohan ML	2009	J Clin Oncol2009，27，：	1
16	Phase Ⅱ study of sorafenib in patients with metastatic or recurrent sarcomas显示文摘	Maki RG D'Adamo DR Keohan ML	2009	J Clin Oncol2009，27，：	1
17	Combined heart and lungtransplantation for unresectahle canliac san*oma显示文摘	TaIbolSM Taub RN’ Keohan ML’	2002	J Thorac (:ard-iovasc Surg2002，124，6：	1
18	Phase D trial of theCDK4 inhibitor PD0332991 in patients with advanced CDK4-am-plified well-differentiated or dedifferentiated liposarcoma 显示文摘	Dickson MA Tap WD Keohan ML	2013	JClin Oncol2013，31，16：	1
19	, Combined heart and lung transplantation for unresectab]e primary cardiac sarcoma显示文摘	Talbot SM Taub RN Keohan ML	2002	J Tho- rac Cardiovasc Surg2002，124，6：	1
20	,Combined heart and lung transplantation for unresectable primary cardiac sarcoma显示文摘	Talbot SM Taub RN Keohan ML	2002	J Tho- rac Cardiovasc Surg2002，124，6：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示